Submit Form Data JavaScript

U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease

ENTYVIO is currently approved for the treatment of moderately to severely active UC and Crohn’s disease in adults.

Some results have been hidden because they may be inaccessible to you